Obliterative bronchiolitis and Dyspnea

Summary:

Dyspnea is found among people with Obliterative bronchiolitis, especially for people who are female, 60+ old.

The study analyzes which people have Dyspnea with Obliterative bronchiolitis. It is created by eHealthMe based on reports of 30 people who have Obliterative bronchiolitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Obliterative bronchiolitis?

Obliterative bronchiolitis (bronchiolar inflammation) is found to be associated with 164 drugs and 490 conditions by eHealthMe. Check the latest studies of Obliterative bronchiolitis.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,724 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

30 people who have Obliterative Bronchiolitis and Dyspnea are studied.

Would you have Dyspnea when you have Obliterative bronchiolitis?

Gender of people who have Obliterative Bronchiolitis and experienced Dyspnea *:

female: 68.97 %
male: 31.03 %

Age of people who have Obliterative Bronchiolitis and experienced Dyspnea *:

Common co-existing conditions for these people *:

High Blood Pressure: 7 people, 23.33%
Influenza Like Illness: 4 people, 13.33%
High Blood Cholesterol: 3 people, 10.00%
Cardiac Valve Disease (heart valve disease): 3 people, 10.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 10.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 10.00%
Asthma: 2 people, 6.67%
Idiopathic Pneumonia Syndrome (pneumonia-like symptoms): 1 person, 3.33%
Immunodeficiency Disorders: 1 person, 3.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.33%

Common drugs taken by these people *:

Prednisone: 6 people, 20.00%
Symbicort: 5 people, 16.67%
Simvastatin: 4 people, 13.33%
Entresto: 4 people, 13.33%
Combivent: 3 people, 10.00%
Methotrexate: 3 people, 10.00%
Nifedipine: 3 people, 10.00%
Augmentin: 3 people, 10.00%
Kaletra: 3 people, 10.00%
Benazepril Hydrochloride: 3 people, 10.00%

Common symptoms for these people *:

Cough: 8 people, 26.67%
Fatigue (feeling of tiredness): 7 people, 23.33%
Chest Pain: 7 people, 23.33%
Fever: 5 people, 16.67%
Lung Disorder (lung disease): 5 people, 16.67%
International Normalised Ratio Increased: 4 people, 13.33%
Inflammation: 4 people, 13.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 10.00%
Nausea (feeling of having an urge to vomit): 3 people, 10.00%
Coronavirus Test Positive: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Obliterative bronchiolitis (2,040 reports)
Dyspnea (661,578 reports)

All the drugs that are associated with Dyspnea:

Dyspnea (3,724 drugs)

All the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Dyspnea and Obliterative bronchiolitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.